Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore the latest research, the science driving these innovative approaches, and what these advances could mean for patients and the future of precision oncology.

Key Topics Covered:

• ALK-positive lung cancer

• Cellular Therapy

• Vaccines

Guests:

Vincent Lam, MD

Associate Professor of Oncology, Johns Hopkins University School of Medicine

Director, Thoracic Oncology Clinical Research Program

Sidney Kimmel Comprehensive Cancer Center

Carmen Mecca. PhD

Postdoctoral Fellow, Chiarle Lab